These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33418509)
1. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509 [TBL] [Abstract][Full Text] [Related]
2. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874 [TBL] [Abstract][Full Text] [Related]
3. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice. Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R J Biol Chem; 2021; 296():100285. PubMed ID: 33450231 [TBL] [Abstract][Full Text] [Related]
4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis. Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876 [TBL] [Abstract][Full Text] [Related]
6. Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants. Van Emburgh BO; Robertson KD Nucleic Acids Res; 2011 Jul; 39(12):4984-5002. PubMed ID: 21378119 [TBL] [Abstract][Full Text] [Related]
7. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression. Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822 [TBL] [Abstract][Full Text] [Related]
8. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164 [TBL] [Abstract][Full Text] [Related]
9. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527 [TBL] [Abstract][Full Text] [Related]
10. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. Gowher H; Jeltsch A J Biol Chem; 2002 Jun; 277(23):20409-14. PubMed ID: 11919202 [TBL] [Abstract][Full Text] [Related]
11. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions. Nowialis P; Lopusna K; Opavska J; Haney SL; Abraham A; Sheng P; Riva A; Natarajan A; Guryanova O; Simpson M; Hlady R; Xie M; Opavsky R Nat Commun; 2019 Sep; 10(1):4374. PubMed ID: 31558711 [TBL] [Abstract][Full Text] [Related]
12. Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis. Redl E; Sheibani-Tezerji R; Cardona CJ; Hamminger P; Timelthaler G; Hassler MR; Zrimšek M; Lagger S; Dillinger T; Hofbauer L; Draganić K; Tiefenbacher A; Kothmayer M; Dietz CH; Ramsahoye BH; Kenner L; Bock C; Seiser C; Ellmeier W; Schweikert G; Egger G Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33310759 [TBL] [Abstract][Full Text] [Related]